Active Concerns Wondering Movers: Sprint Corporation (NYSE:S), Exelon Corporation (NYSE:EXC)

Sprint Corporation (NYSE:S) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 1.32% to close at $9.23 with the total traded volume of 36.43 Million shares. Sprint Corp.(S) reported that a narrower net loss in the third-quarter. It declared more than 5 percent year-over-year growth in net operating revenues and the highest postpaid phone net additions in four years. The company also declared operating income of $311 million and Adjusted EBITDA of $2.5 billion, both improvements of more than $500 million year-over-year.”Sprint is turning the corner,” said Sprint CEO Marcelo Claure.

“Even with all the aggressive promotional offers from our competitors, we were still able to add more postpaid phone consumers than both Verizon and AT&T while continuing to grow revenues, take costs out of the business, and improve the network.”Looking ahead for fiscal year 2016, the company now expects Adjusted EBITDA of $9.7 billion to $10 billion, at the high end of its previous expectation of $9.5 billion to $10 billion. The company now expects operating income of $1.4 billion to $1.7 billion, at the high end of its previous expectation of $1.2 billion to $1.7 billion. The firm has institutional ownership of 16.80%, while insider ownership included 0.20%. Its price to sales ratio ended at 1.13. S attains analyst recommendation of 2.70 with week performance of 0.44%.

Exelon Corporation (NYSE:EXC) [Trend Analysis] surged reacts as active mover, shares an advance 2.40% to traded at $35.88 and the percentage gap between open changing to regular change was 0.00%. The BOD of Exelon Corporation declared a regular quarterly dividend of $0.3275 per share on Exelon’s common stock. The dividend is payable on March 10, 2017, to shareholders of record of Exelon as of 5 p.m. New York time on Feb. 15, 2017.

The dividend surged from the previous amount of $0.318 per share, consistent with the Board’s Feb. 3, 2016, decision to raise Exelon’s dividend by 2.5 percent annually through 2018. The firm’s current ratio calculated as 1.00 for the most recent quarter. The firm past twelve months price to sales ratio was 1.10 and price to cash ratio remained 17.46. As far as the returns are concern, the return on equity was recorded as 4.80% and return on investment was 6.40% while its return on asset stayed at 1.10%. The firm has total debt to equity ratio measured as 1.39.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *